• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Inferring effects of mutations on SARS-CoV-2 transmission from genomic surveillance data

tetano

Editor, Senior Moderator
Nat Commun


. 2025 Jan 7;16(1):441.
doi: 10.1038/s41467-024-55593-0. Inferring effects of mutations on SARS-CoV-2 transmission from genomic surveillance data

Brian Lee[SUP] 1 [/SUP], Ahmed Abdul Quadeer[SUP] 2 3 [/SUP], Muhammad Saqib Sohail[SUP] 2 4 [/SUP], Elizabeth Finney[SUP] 1 [/SUP], Syed Faraz Ahmed[SUP] 2 3 5 [/SUP], Matthew R McKay[SUP] 6 7 8 9 [/SUP], John P Barton[SUP] 10 11 12 [/SUP]



Affiliations
Abstract

New and more transmissible variants of SARS-CoV-2 have arisen multiple times over the course of the pandemic. Rapidly identifying mutations that affect transmission could improve our understanding of viral biology and highlight new variants that warrant further study. Here we develop a generic, analytical epidemiological model to infer the transmission effects of mutations from genomic surveillance data. Applying our model to SARS-CoV-2 data across many regions, we find multiple mutations that substantially affect the transmission rate, both within and outside the Spike protein. The mutations that we infer to have the largest effects on transmission are strongly supported by experimental evidence from prior studies. Importantly, our model detects lineages with increased transmission even at low frequencies. As an example, we infer significant transmission advantages for the Alpha, Delta, and Omicron variants shortly after their appearances in regional data, when they comprised only around 1-2% of sample sequences. Our model thus facilitates the rapid identification of variants and mutations that affect transmission from genomic surveillance data.


 
Back
Top Bottom